dacarbazine has been researched along with Kaposi Disease in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bailey, A; Bennani, YL; Bom, D; Boozer, S; Brunden, K; Dent, T; Gleason, E; Harrington, J; Huck, B; Leventhal, C; Murphy, S; Rundlett, S; Sherf, B; Silver, D; Tumey, LN; Wang, J | 1 |
1 other study(ies) available for dacarbazine and Kaposi Disease
Article | Year |
---|---|
The identification and optimization of a N-hydroxy urea series of flap endonuclease 1 inhibitors.
Topics: Cell Line, Tumor; Dacarbazine; DNA Damage; Enzyme Inhibitors; Flap Endonucleases; Humans; Methyl Methanesulfonate; Structure-Activity Relationship; Temozolomide; Urea; Urinary Bladder Neoplasms; Xeroderma Pigmentosum | 2005 |